WOMEN 'S HEALTH AND MENOPAUSE : - National Heart, Lung ...

REFERENCES
1 Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the
worldwide mortality from 25 cancers in 1990
[published erratum appears in Int J Cancer
1999;83(6):870-3]. Int J Cancer 1999;83(1):18–29.
2 Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide
incidence of 25 major cancers in 1990. Int J
Cancer 1999;80(6):827–41.
3 Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer
statistics, 2000. CA Cancer J Clin 2000;50(1):7–33.
4 Pike MC. Age-related factors in cancer of the breast,
ovary, and endometrium. J Chronic Dis
1987;40(Suppl 2):59S–69S.
5 La Vecchia C. Reproductive surgery, menopause and
breast cancer risk. Eur J Cancer 1999;35(1):12–3.
6 Lipworth L. Epidemiology of breast cancer (review).
Eur J Cancer Prev 1995;4(1):7–30.
7 Trichopoulos D, MacMahon B, Cole P. Menopause
and breast cancer risk. J Natl Cancer Inst
1972;48(3):605–13.
8 Alexander FE, Roberts MM. The menopause and
breast cancer (review). J Epidemiol Community
Health 1987;41(2):94–100.
9 Brinton LA, Schairer C, Hoover RN, Fraumeni JF Jr.
Menstrual factors and risk of breast cancer. Cancer
Invest 1988;6(3):245–54.
10 Collaborative Group on Hormonal Factors in Breast
Cancer. Breast cancer and hormone replacement
therapy: collaborative reanalysis of data from 51
epidemiological studies of 52,705 women with
breast cancer and 108,411 women without breast
cancer. Lancet 1997;350(9084):1047–59.
11 Helmrich SP, Shapiro S, Rosenberg L, et al. Risk
factors for breast cancer. Am J Epidemiol
1983;117(1):35–45.
244
12 Carter CL, Jones DY, Schatzkin A, Brinton LA.
A prospective study of reproductive, familial,
and socioeconomic risk factors for breast cancer
using NHANES I data. Public Health Rep
1989;104(1):45–50.
13 Pike MC, Ross RK, Spicer DV. Problems involved
in including women with simple hysterectomy in
epidemiologic studies measuring the effects of
hormone replacement therapy on breast cancer risk.
Am J Epidemiol 1998;147(8);718–21.
14 Braga C, Negri E, La Vecchia C, Franceschi S. Age
at menopause and breast cancer: estimation of
floating absolute risks. The Breast 1998;7:27–32.
15 Easton DF, Peto J, Babiker AG. Floating absolute
risk: an alternative to relative risk in survival and
case-control analysis avoiding and arbitrary reference
group. Stat Med 1991;10(7):1025–35.
16 Parazzini F, Franceschi S, La Vecchia C, Fasoli M.
Epidemiology of ovarian cancer (review). Gynecol
Oncol 1991;43(1):9–23.
17 Parazzini F, La Vecchia C, Bocciolone L, Franceschi
S. The epidemiology of endometrial cancer
(review). Gynecol Oncol 1991;41(1):1–16.
18 Negri E, La Vecchia C, Parazzini F, et al.
Reproductive and menstrual factors and
risk of colorectal cancer. Cancer Res
1989;49(24Pt1):7158–61.
19 Clinical Synthesis Panel on HRT. Hormone replacement
therapy. Lancet 1999;354(9173):152–5.
20 IARC, International Agency for Research on Cancer.
IARC Monograph on the Evaluation of
Carcinogenic Risks to Humans, Vol.72. Hormonal
Contraception and Post-menopausal Hormonal
Therapy. IARC, Lyon, 1999.
21 Brinton LA, Schairer C. Postmenopausal hormonereplacement
therapy—Time for a reappraisal?
(Editorial). N Engl J Med 1997;336(25):1821–2.